Clinical Trial Update: A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1 [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports completion of Phase 1 and Phase 2 studies evaluating terlipressin in patients with Hepatorenal Syndrome Type 1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatorenal Syndrome Type 1

Drugs mentioned

• Terlipressin (terlipressin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Hepatorenal Syndrome Type 1 | Phase 1, Phase 2 | Status: COMPLETED